Mapping the energetic and allosteric landscapes of protein binding domains

被引:0
作者
Andre J. Faure
Júlia Domingo
Jörn M. Schmiedel
Cristina Hidalgo-Carcedo
Guillaume Diss
Ben Lehner
机构
[1] The Barcelona Institute of Science and Technology,Center for Genomic Regulation (CRG)
[2] Universitat Pompeu Fabra (UPF),undefined
[3] Institució Catalana de Recerca i Estudis Avançats (ICREA),undefined
[4] New York Genome Center (NYGC),undefined
[5] Friedrich Miescher Institute for Biomedical Research (FMI),undefined
来源
Nature | 2022年 / 604卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Allosteric communication between distant sites in proteins is central to biological regulation but still poorly characterized, limiting understanding, engineering and drug development1–6. An important reason for this is the lack of methods to comprehensively quantify allostery in diverse proteins. Here we address this shortcoming and present a method that uses deep mutational scanning to globally map allostery. The approach uses an efficient experimental design to infer en masse the causal biophysical effects of mutations by quantifying multiple molecular phenotypes—here we examine binding and protein abundance—in multiple genetic backgrounds and fitting thermodynamic models using neural networks. We apply the approach to two of the most common protein interaction domains found in humans, an SH3 domain and a PDZ domain, to produce comprehensive atlases of allosteric communication. Allosteric mutations are abundant, with a large mutational target space of network-altering ‘edgetic’ variants. Mutations are more likely to be allosteric closer to binding interfaces, at glycine residues and at specific residues connecting to an opposite surface within the PDZ domain. This general approach of quantifying mutational effects for multiple molecular phenotypes and in multiple genetic backgrounds should enable the energetic and allosteric landscapes of many proteins to be rapidly and comprehensively mapped.
引用
收藏
页码:175 / 183
页数:8
相关论文
共 115 条
[1]  
Guarnera E(2020)Allosteric drugs and mutations: chances, challenges, and necessity Curr. Opin. Struct. Biol. 62 149-157
[2]  
Berezovsky IN(2014)Small-molecule inhibitors of protein-protein interactions: progressing toward the reality Chem. Biol. 21 1102-1114
[3]  
Arkin MR(2014)The ensemble nature of allostery Nature 508 331-339
[4]  
Tang Y(2020)Protein topology and allostery Curr. Opin. Struct. Biol. 62 158-165
[5]  
Wells JA(2007)The origin of protein interactions and allostery in colocalization Nature 450 983-990
[6]  
Motlagh HN(2013)Allostery in disease and in drug discovery Cell 153 293-305
[7]  
Wrabl JO(1963)Allosteric proteins and cellular control systems J. Mol. Biol. 6 306-329
[8]  
Li J(2011)In memoriam: Jacques Monod (1910–1976) Genome Biol. Evol. 3 1025-1033
[9]  
Hilser VJ(2009)Protein sectors: evolutionary units of three-dimensional structure Cell 138 774-786
[10]  
Xie J(2021)Protein context shapes the specificity of SH3 domain-mediated interactions in vivo Nat. Commun. 12 e68346-1575